Home / Tag Archives: Exicure

News: Exicure


$790M Deal Reached For Potential Psoriasis Treatment, AST-005

AST-005 Purdue

Purdue Pharma and Exicure have announced a strategic research alliance and licensing agreement for AST-005, a potential treatment for psoriasis and other diseases amenable to a gene regulation approach by Exicure called spherical nucleic acid (SNA) technology. Purdue will own full global rights to AST-005, among other collaboration targets. Together with …

Read More »